메뉴 건너뛰기




Volumn 1, Issue 9, 2011, Pages

Comorbidity as a prognostic variable in multiple myeloma: Comparative evaluation of common comorbidity scores and use of a novel MM-comorbidity score

Author keywords

Comorbidities; Comorbidity scores; Multiple myeloma; Prognosis

Indexed keywords

CREATININE; DEXAMETHASONE; EPIRUBICIN; ETOPOSIDE; IDARUBICIN; IFOSFAMIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LIGHT CHAIN; IMMUNOGLOBULIN M; MELPHALAN; PREDNISONE; THALIDOMIDE;

EID: 84856853048     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2011.34     Document Type: Article
Times cited : (88)

References (45)
  • 1
    • 33746358830 scopus 로고    scopus 로고
    • State of the art therapy in multiple myeloma and future perspectives
    • DOI 10.1016/j.ejca.2005.11.040, PII S0959804906003248
    • Denz U, Haas PS, Wasch R, Einsele H, Engelhardt M. State of the art therapy in multiple myeloma and future perspectives. Eur J Cancer 2006; 42: 1591-1600. (Pubitemid 44118774)
    • (2006) European Journal of Cancer , vol.42 , Issue.11 , pp. 1591-1600
    • Denz, U.1    Haas, P.S.2    Wasch, R.3    Einsele, H.4    Engelhardt, M.5
  • 2
    • 33746337292 scopus 로고    scopus 로고
    • 160 years of multiple myeloma: Progress and challenges
    • DOI 10.1016/j.ejca.2006.05.003, PII S095980490600390X
    • Engelhardt M, Mertelsmann R. 160 Years of multiple myeloma: progress and challenges. Eur J Cancer 2006; 42: 1507-1509. (Pubitemid 44118777)
    • (2006) European Journal of Cancer , vol.42 , Issue.11 , pp. 1507-1509
    • Engelhardt, M.1    Mertelsmann, R.2
  • 3
    • 0016804136 scopus 로고
    • A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival
    • Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975; 36: 842-854.
    • (1975) Cancer , vol.36 , pp. 842-854
    • Durie, B.G.1    Salmon, S.E.2
  • 5
    • 77953616666 scopus 로고    scopus 로고
    • Prognostic factor and quality of life analysis in 160 patients aged 4 or=60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation
    • Deschler B, Binek K, Ihorst G, Marks R, Wasch R, Bertz H et al. Prognostic factor and quality of life analysis in 160 patients aged 4 or=60 years with hematologic neoplasias treated with allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2010; 16: 967-975.
    • (2010) Biol Blood Marrow Transplant , vol.16 , pp. 967-975
    • Deschler, B.1    Binek, K.2    Ihorst, G.3    Marks, R.4    Wasch, R.5    Bertz, H.6
  • 7
    • 70449464264 scopus 로고    scopus 로고
    • Comorbidity as prognostic variable in MDS: Comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group
    • Sperr WR, Wimazal F, Kundi M, Baumgartner C, Nosslinger T, Makrai A et al. Comorbidity as prognostic variable in MDS: comparative evaluation of the HCT-CI and CCI in a core dataset of 419 patients of the Austrian MDS Study Group. Ann Oncol 2009; 21: 114-119.
    • (2009) Ann Oncol , vol.21 , pp. 114-119
    • Sperr, W.R.1    Wimazal, F.2    Kundi, M.3    Baumgartner, C.4    Nosslinger, T.5    Makrai, A.6
  • 8
    • 34948869819 scopus 로고    scopus 로고
    • Comorbidity and disease status-based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation
    • DOI 10.1200/JCO.2006.09.7865
    • Sorror ML, Sandmaier BM, Storer BE, Maris MB, Baron F, Maloney DG et al. Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation. J Clin Oncol 2007; 25: 4246-4254. (Pubitemid 47554249)
    • (2007) Journal of Clinical Oncology , vol.25 , Issue.27 , pp. 4246-4254
    • Sorror, M.L.1    Sandmaier, B.M.2    Storer, B.E.3    Maris, M.B.4    Baron, F.5    Moloney, D.G.6    Scott, B.L.7    Deeg, H.J.8    Appelbaum, F.R.9    Storb, R.10
  • 9
    • 33947499161 scopus 로고    scopus 로고
    • Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
    • DOI 10.1002/cncr.22537
    • Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D et al. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer 2007; 109: 1376-1383. (Pubitemid 46466565)
    • (2007) Cancer , vol.109 , Issue.7 , pp. 1376-1383
    • Etienne, A.1    Esterni, B.2    Charbonnier, A.3    Mozziconacci, M.-J.4    Arnoulet, C.5    Coso, D.6    Puig, B.7    Gastaut, J.-A.8    Maraninchi, D.9    Vey, N.10
  • 10
    • 23944440464 scopus 로고    scopus 로고
    • Hematopoietic cell transplantation (HCT)-specific comorbidity index: A new tool for risk assessment before allogeneic HCT
    • DOI 10.1182/blood-2005-05-2004
    • Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912-2919. (Pubitemid 41510773)
    • (2005) Blood , vol.106 , Issue.8 , pp. 2912-2919
    • Sorror, M.L.1    Maris, M.B.2    Storb, R.3    Baron, F.4    Sandmaier, B.M.5    Maloney, D.G.6    Storer, B.7
  • 14
    • 34447316440 scopus 로고    scopus 로고
    • Monitoring of renal function in cancer patients: An ongoing challenge for clinical practice
    • DOI 10.1093/annonc/mdm055
    • Kleber M, Cybulla M, Bauchmuller K, Ihorst G, Koch B, Engelhardt M. Monitoring of renal function in cancer patients: an ongoing challenge for clinical practice. Ann Oncol 2007; 18: 950-958. (Pubitemid 47054095)
    • (2007) Annals of Oncology , vol.18 , Issue.5 , pp. 950-958
    • Kleber, M.1    Cybulla, M.2    Bauchmller, K.3    Ihorst, G.4    Koch, B.5    Engelhardt, M.6
  • 15
    • 33744958852 scopus 로고    scopus 로고
    • Assessing kidney function - Measured and estimated glomerular filtration rate
    • DOI 10.1056/NEJMra054415
    • Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 2006; 354: 2473-2483. (Pubitemid 43855050)
    • (2006) New England Journal of Medicine , vol.354 , Issue.23 , pp. 2473-2483
    • Stevens, L.A.1    Coresh, J.2    Greene, T.3    Levey, A.S.4
  • 17
    • 79951891171 scopus 로고    scopus 로고
    • Renal impairment in patients with multiple myeloma: A consensus statement on behalf of the International Myeloma Working Group
    • Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol 2010; 28: 4976-4984.
    • (2010) J Clin Oncol , vol.28 , pp. 4976-4984
    • Dimopoulos, M.A.1    Terpos, E.2    Chanan-Khan, A.3    Leung, N.4    Ludwig, H.5    Jagannath, S.6
  • 18
    • 70449503311 scopus 로고    scopus 로고
    • Detection of renal impairment as one specific comorbidity factor in multiple myeloma: Multicenter study in 198 consecutive patients
    • Kleber M, Ihorst G, Deschler B, Jakob C, Liebisch P, Koch B et al. Detection of renal impairment as one specific comorbidity factor in multiple myeloma: multicenter study in 198 consecutive patients. Eur J Haematol 2009; 83: 519-527.
    • (2009) Eur J Haematol , vol.83 , pp. 519-527
    • Kleber, M.1    Ihorst, G.2    Deschler, B.3    Jakob, C.4    Liebisch, P.5    Koch, B.6
  • 19
    • 33644829447 scopus 로고    scopus 로고
    • Early mortality after diagnosis of multiple myeloma: Analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party
    • Augustson BM, Begum G, Dunn JA, Barth NJ, Davies F, Morgan G et al. Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United kingdom Medical Research Council trials between 1980 and 2002-Medical Research Council Adult Leukaemia Working Party. J Clin Oncol 2005; 23: 9219-9226.
    • (2005) J Clin Oncol , vol.23 , pp. 9219-9226
    • Augustson, B.M.1    Begum, G.2    Dunn, J.A.3    Barth, N.J.4    Davies, F.5    Morgan, G.6
  • 20
    • 77951923656 scopus 로고    scopus 로고
    • Survival and years of life lost in different age cohorts of patients with multiple myeloma
    • Ludwig H, Bolejack V, Crowley J, Blade J, Miguel JS, Kyle RA et al. Survival and years of life lost in different age cohorts of patients with multiple myeloma. J Clin Oncol 2010; 28: 1599-1605.
    • (2010) J Clin Oncol , vol.28 , pp. 1599-1605
    • Ludwig, H.1    Bolejack, V.2    Crowley, J.3    Blade, J.4    Miguel, J.S.5    Kyle, R.A.6
  • 21
    • 34648864233 scopus 로고    scopus 로고
    • Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients
    • DOI 10.1007/s00432-007-0233-x
    • Wedding U, Rohrig B, Klippstein A, Pientka L, Hoffken K. Age, severe comorbidity and functional impairment independently contribute to poor survival in cancer patients. J Cancer Res Clin Oncol 2007; 133: 945-950. (Pubitemid 47561710)
    • (2007) Journal of Cancer Research and Clinical Oncology , vol.133 , Issue.12 , pp. 945-950
    • Wedding, U.1    Rohrig, B.2    Klippstein, A.3    Pientka, L.4    Hoffken, K.5
  • 22
    • 79955002002 scopus 로고    scopus 로고
    • Comorbidities and hematopoietic cell transplantation outcomes
    • Sorror ML. Comorbidities and hematopoietic cell transplantation outcomes. Hematology Am Soc Hematol Educ Program 2010; 2010: 237-247.
    • (2010) Hematology Am Soc Hematol Educ Program , vol.2010 , pp. 237-247
    • Sorror, M.L.1
  • 24
    • 58149290243 scopus 로고    scopus 로고
    • Chemotherapy safety and severe adverse events in cancer patients: Strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment
    • Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-728.
    • (2009) Int J Cancer , vol.124 , pp. 722-728
    • Markert, A.1    Thierry, V.2    Kleber, M.3    Behrens, M.4    Engelhardt, M.5
  • 25
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • DOI 10.1016/0021-9681(87)90171-8
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383. (Pubitemid 17055592)
    • (1987) Journal of Chronic Diseases , vol.40 , Issue.5 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.A.3    MacKenzie, C.R.4
  • 26
    • 0016205557 scopus 로고
    • The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus
    • Kaplan MH, Feinstein AR. The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974; 27: 387-404.
    • (1974) J Chronic Dis , vol.27 , pp. 387-404
    • Kaplan, M.H.1    Feinstein, A.R.2
  • 27
    • 0028156819 scopus 로고
    • The effect of comorbidity on 3-year survival of women with primary breast cancer
    • Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104-110. (Pubitemid 24027550)
    • (1994) Annals of Internal Medicine , vol.120 , Issue.2 , pp. 104-110
    • Satariano, W.A.1    Ragland, D.R.2
  • 28
    • 79551627594 scopus 로고    scopus 로고
    • Association of multiple myeloma with different neoplasms: Systematic analysis in consecutive patients with myeloma
    • Hasskarl J, Ihorst G, De Pasquale D, Schrottner P, Zerweck A, Wasch R et al. Association of multiple myeloma with different neoplasms: systematic analysis in consecutive patients with myeloma. Leuk Lymphoma 2010; 52: 247-259.
    • (2010) Leuk Lymphoma , vol.52 , pp. 247-259
    • Hasskarl, J.1    Ihorst, G.2    De Pasquale, D.3    Schrottner, P.4    Zerweck, A.5    Wasch, R.6
  • 29
    • 0026708195 scopus 로고
    • C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system
    • Bataille R, Boccadoro M, Klein B, Durie B, Pileri A. C-reactive protein and beta-2 microglobulin produce a simple and powerful myeloma staging system. Blood 1992; 80: 733-737.
    • (1992) Blood , vol.80 , pp. 733-737
    • Bataille, R.1    Boccadoro, M.2    Klein, B.3    Durie, B.4    Pileri, A.5
  • 30
    • 0021988988 scopus 로고
    • Staging systems for multiple myeloma: A comparison
    • Gassmann W, Pralle H, Haferlach T, Pandurevic S, Graubner M, Schmitz N et al. Staging systems for multiple myeloma: a comparison. Br J Haematol 1985; 59: 703-711. (Pubitemid 15133663)
    • (1985) British Journal of Haematology , vol.59 , Issue.4 , pp. 703-711
    • Gassmann, W.1    Pralle, H.2    Haferlach, T.3
  • 32
    • 0028880424 scopus 로고
    • Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities
    • Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH et al. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995; 86: 4250-4256.
    • (1995) Blood , vol.86 , pp. 4250-4256
    • Tricot, G.1    Barlogie, B.2    Jagannath, S.3    Bracy, D.4    Mattox, S.5    Vesole, D.H.6
  • 34
    • 33747355260 scopus 로고    scopus 로고
    • Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation
    • Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O et al. Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006; 12: 954-964.
    • (2006) Biol Blood Marrow Transplant , vol.12 , pp. 954-964
    • Artz, A.S.1    Pollyea, D.A.2    Kocherginsky, M.3    Stock, W.4    Rich, E.5    Odenike, O.6
  • 35
    • 77949327961 scopus 로고    scopus 로고
    • Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes
    • Nosslinger T, Tuchler H, Germing U, Sperr WR, Krieger O, Haase D et al. Prognostic impact of age and gender in 897 untreated patients with primary myelodysplastic syndromes. Ann Oncol 2009; 21: 120-125.
    • (2009) Ann Oncol , vol.21 , pp. 120-125
    • Nosslinger, T.1    Tuchler, H.2    Germing, U.3    Sperr, W.R.4    Krieger, O.5    Haase, D.6
  • 37
    • 0033851432 scopus 로고    scopus 로고
    • Renal failure in multiple myeloma: Reversibility and impact on the prognosis. Nordic Myeloma Study Group
    • Knudsen LM, Hjorth M, Hippe E. Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 2000; 65: 175-181.
    • (2000) Eur J Haematol , vol.65 , pp. 175-181
    • Knudsen, L.M.1    Hjorth, M.2    Hippe, E.3
  • 38
    • 21044439673 scopus 로고    scopus 로고
    • Autologous stem cell transplantation in multiple myeloma: Outcome in patients with renal failure
    • DOI 10.1111/j.1600-0609.2005.00446.x
    • Knudsen LM, Nielsen B, Gimsing P, Geisler C. Autologous stem cell transplantation in multiple myeloma: outcome in patients with renal failure. Eur J Haematol 2005; 75: 27-33. (Pubitemid 40873958)
    • (2005) European Journal of Haematology , vol.75 , Issue.1 , pp. 27-33
    • Knudsen, L.M.1    Nielsen, B.2    Gimsing, P.3    Geisler, C.4
  • 39
    • 61749083453 scopus 로고    scopus 로고
    • Carbon monoxide diffusion capacity: How low can you go for hematopoietic cell transplantation eligibility?
    • Chien JW, Sullivan KM. Carbon monoxide diffusion capacity: how low can you go for hematopoietic cell transplantation eligibility? Biol Blood Marrow Transplant 2009; 15: 447-453.
    • (2009) Biol Blood Marrow Transplant , vol.15 , pp. 447-453
    • Chien, J.W.1    Sullivan, K.M.2
  • 40
    • 49449099401 scopus 로고    scopus 로고
    • Utility of comorbidity assessment in predicting transplantation- related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma
    • Labonte L, Iqbal T, Zaidi MA, McDiarmid SA, Huebsch LB, Tay J et al. Utility of comorbidity assessment in predicting transplantation- related toxicity following autologous hematopoietic stem cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2008; 14: 1039-1044.
    • (2008) Biol Blood Marrow Transplant , vol.14 , pp. 1039-1044
    • Labonte, L.1    Iqbal, T.2    Zaidi, M.A.3    McDiarmid, S.A.4    Huebsch, L.B.5    Tay, J.6
  • 41
    • 67349250764 scopus 로고    scopus 로고
    • The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation
    • Farina L, Bruno B, Patriarca F, Spina F, Sorasio R, Morelli M et al. The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation. Leukemia 2009; 23: 1131-1138.
    • (2009) Leukemia , vol.23 , pp. 1131-1138
    • Farina, L.1    Bruno, B.2    Patriarca, F.3    Spina, F.4    Sorasio, R.5    Morelli, M.6
  • 43
    • 0344742274 scopus 로고    scopus 로고
    • Cancer Survival and Incidence from, the Surveillance, Epidemiology, and End Results (SEER) Program
    • DOI 10.1634/theoncologist.8-6-541
    • Gloeckler Ries LA, Reichman ME, Lewis DR, Hankey BF, Edwards BK. Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program. Oncologist 2003; 8: 541-552. (Pubitemid 37467370)
    • (2003) Oncologist , vol.8 , Issue.6 , pp. 541-552
    • Ries, L.A.G.1    Reichman, M.E.2    Lewis, D.R.3    Hankey, B.F.4    Edwards, B.K.5
  • 44
    • 0037086065 scopus 로고    scopus 로고
    • Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer
    • DOI 10.1016/S0360-3016(01)02741-9, PII S0360301601027419
    • Firat S, Bousamra M, Gore E, Byhardt RW. Comorbidity and KPS are independent prognostic factors in stage I nonsmall- cell lung cancer. Int J Radiat Oncol Biol Phys 2002; 52: 1047-1057. (Pubitemid 34219026)
    • (2002) International Journal of Radiation Oncology Biology Physics , vol.52 , Issue.4 , pp. 1047-1057
    • Firat, S.1    Bousamra, M.2    Gore, E.3    Byhardt, R.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.